Stewardship Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$232K Sell
463
-1
-0.2% -$480 0.05% 160
2026
Q1
$228K Sell
464
-15
-3% -$8.14K 0.05% 148
2025
Q4
$278K Buy
479
+19
+4% +$10.7K 0.06% 122
2025
Q3
$223K Buy
+460
New +$214K 0.05% 143
2025
Q2
Sell
-467
Closed -$232K 159
2025
Q1
$232K Buy
467
+32
+7% +$17.3K 0.06% 129
2024
Q4
$226K Buy
435
+3
+0.7% +$1.65K 0.06% 138
2024
Q3
$267K Buy
+432
New +$256K 0.08% 114

Other funds holding TMO

Stewardship Advisors's TMO Position: Q2 2026 in Review

Stewardship Advisors reduced its Thermo Fisher Scientific (TMO) stake by 0.22% in Q2 2026, selling an estimated $480 and leaving 463 shares worth $232K. The position accounts for 0.05% of the portfolio, ranked #160.

Stewardship Advisors first reported a position in TMO in Q3 2024 and has held it in 7 quarters since. The position peaked at $278K in Q4 2025. 1,147 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Stewardship Advisors held 463 shares of Thermo Fisher Scientific worth $232K as of Q2 2026.
  • Stewardship Advisors sold 1 Thermo Fisher Scientific share in Q2 2026, an estimated $480.
  • Thermo Fisher Scientific made up 0.05% of Stewardship Advisors's portfolio in Q2 2026, its #160 holding.
  • Stewardship Advisors first reported a position in Thermo Fisher Scientific in Q3 2024 and has held it in 7 quarters since.
  • Stewardship Advisors's Thermo Fisher Scientific position peaked at $278K in Q4 2025.
  • 1,147 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Stewardship Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.